Efficacy of radium-223 in bone-metastatic prostate cancer patients with and without homologous repair deficiency (HRD) mutations.

e17023Background: Inactivating mutations in genes mediating homologous recombination DNA-repair (HRD) are present in 20-30% of men with metastatic castrate-resistant prostate cancer (mCRPC). Radium...